A simple blood test correctly identified most colorectal cancers in an early trial of the technology, offering the possibility of a convenient screening test that could be done during routine checkups, the company which developed it said on Wednesday.
The test, being developed by Danish biotech company Exiqon, worked well at both identifying colon cancers and at ruling them out, the company said at an American Association for Cancer Research meeting in Denver.
“Our test has the potential to be safe, cheap, robust, accurate and of little or no inconvenience to the individual,” Soren Nielsen, the company’s scientific manager of diagnostic product development, said in a statement. [Read more...]





